单孔机器人辅助前列腺癌根治术专家共识  

Expert consensus statement of single-site robot-assisted radical prostatectomy from the Robotics Group of Urology branch of Chinese Medical Association

作　　者：王东[1] 郭剑明 古迪 李恭会[4] 马利民[5] 任善成 王保军 王德林[8] 王龙 徐东亮 叶雄俊 朱清毅 任尚青 Wang Dong;Guo Jianming;Gu Di;Li Gonghui;Ma Liming;Ren Shancheng;Wang Baojun;Wang Delin;Wang Long;Xu Dongliang;Ye Xiongjun;Zhu Qingyi;Ren Shangqing(Robotic Minimally Invasive Surgery Center,Sichuan Academy of Medical Sciences·Sichuan Pro-vincial People’s Hospital,Chendu 610072,China;Department of Urology,the Affiliated Zhong-shan Hospital of Fudan University,Shanghai 200032,China;Department of Urology,the Affiliat-ed Hospital of Guangzhou Medical University,Guangzhou 510000,China;Department of Urolo-gy,the Affiliated Sir Run Run Shaw Hospital of Zhejiang University School of Medicine,Hang-zhou 310016,China;Department of Urology,the Affiliated Hospital of Nantong University,Nan-tong 226001,China;Department of Urology,the Second Affiliated Hospital of Navial Medical Uni-versity,Shanghai 200003,China;Department of Urology,the Third Medical Center,People’s Liberation Army Hospital,Beijing 100039,China;Department of Urology,the First Affiliated Hos-pital of Chongqing Medical University,Chongqing 400016,China;Department of Urology,the Third Xiangya Hospital of Central South University,Changsha 410013,China;Department of Urology,the Affiliated Shuguang Hospital of Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Urology,Cancer Hospital Chinese Academy of Medical Sciences,Beijing 100021,China;Department of Urology,the Second Affiliated Hospital of Nan-jing Medical University,Nanjing 210011,China)

机构地区：[1]四川省医学科学院·四川省人民医院机器人微创中心,成都610072 [2]复旦大学附属中山医院泌尿外科,上海200032 [3]广州医科大学附属第一医院泌尿外科,广州510000 [4]浙江大学医学院附属邵逸夫医院泌尿外科,杭州310016 [5]南通大学附属医院泌尿外科,南通226001 [6]海军军医大学第二附属医院泌尿外科,上海200003 [7]中国人民解放军总医院第三医学中心泌尿外科,北京100039 [8]重庆医科大学附属第一医院泌尿外科,重庆400016 [9]中南大学湘雅三医院泌尿外科,长沙410013 [10]上海中医药大学附属曙光医院泌尿外科,上海201203 [11]中国医学科学院肿瘤医院泌尿外科,北京100021 [12]南京医科大学第二附属医院泌尿外科,南京210011

出　　处：《微创泌尿外科杂志》2023年第1期18-24,共7页Journal of Minimally Invasive Urology

摘　　要：机器人辅助前列腺癌根治术(RARP)已成为治疗局限性前列腺癌(PCa)的主流术式。2008年以来,针对特定患者人群,国内外学者开始采用不同入路方式开展单孔RARP(ssRARP),取得了良好效果,并有较多文献发表。本共识编写组建议:ssRARP需要选择最佳适应证人群,特别是局限性、T1~T2c中低危PCa患者;根据患者不同特点、术者习惯和经验以及平台资源,具体制定腹膜外(含改良)、腹腔、会阴、da Vinci SP等不同入路方式ssRARP,并采取对应的泊机方式和手术步骤;需注重手术技巧改进和防治特异性并发症等。针对特定患者,个体化制定不同入路ssRARP和对应的操作,有利于在取得良好临床疗效基础上使患者获益更大。Robot-assisted radical prostatectomy(RARP)has become the mainstream procedure for the treat⁃ment of localized prostate cancer(PCa).Since 2008,for specific patient populations,domestic and foreign scholars have begun to implement single-site robot assisted radical prostatectomy(ssRARP)with different approaches,which has achieved good results,and many literatures have been published.Based on the experience of each center,pub⁃lished articles,expert opinions,and questionnaires,to make recommendations for the surgical procedure names that have not been unified,and to conduct a consensus review of the existing ssRARP procedures and clinical data.Con⁃vened by the Robotics Group of Urology branch of Chinese Medical Association,the ssRARP consensus group sum⁃marized the consensus of experts on ssRARP through literature search and questionnaire survey.Current data suggest that ssRARP has a good effect.Different from conventional multiport RARP,the consensus group suggested that ss⁃RARP should be selected for the best indication population,especially for patients with localized,T1-T2C medium-low risk PCa;according to the different characteristics of the patients,the habits and experience of the surgeons and the platform resources,different approaches such as extraperitoneal(including modified),transperitoneal,transperi⁃neal,da Vinci SP and other approaches are specifically formulated for ssRARP,and the corresponding docking meth⁃ods and surgical procedures are adopted;focus on the improvement of surgical techniques and the prevention and treatment of specific complications.The individualized formulation of different ssRARP approaches and corresponding procedures will be more beneficial for specific patients on the basis of good clinical effect.

关 键 词：前列腺肿瘤 机器人 单孔 

分 类 号：R737.25[医药卫生—肿瘤]